Residual antimicrobial coating efficacy against SARS-CoV-2.

Rachael L HardisonShawn P RyanRebecca A LimmerMargaret CrouseSarah W NelsonDaniela BarrigaJessica M GhereMichael J StewartSang Don LeeBrian M TaylorRyan R JamesMichael Worth CalfeeMegan W Howard

Published in: Journal of applied microbiology (2022)

This study highlights the formulation-specific efficacy of several products against SARS-CoV-2 and may inform future development of residual antiviral products for use on non-porous surfaces. The identification of antimicrobial coatings or films showing promise to inactivate SARS-CoV-2 suggests that these products may be worth future testing and consideration.

Keyphrases

sars cov
respiratory syndrome coronavirus
staphylococcus aureus
current status
drug delivery
machine learning
biofilm formation
escherichia coli
deep learning
candida albicans